Loading
Latest filing published 30 Aug 2021 for Kindred Biosciences, Inc., €506k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Hangjun Zhan discloses dealings in Kindred Biosciences, Inc. to SEC (Form 4). The record holds 13 filings, for trades running from 23 January 2018 to 27 August 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 30 August 2021, the filings show a transaction worth €506k in Kindred Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration